Cargando…
Revisiting the cardiovascular risk of hydroxychloroquine in RA
Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoi...
Autores principales: | Pers, Yves-Marie, Padern, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525224/ https://www.ncbi.nlm.nih.gov/pubmed/32999492 http://dx.doi.org/10.1038/s41584-020-00521-x |
Ejemplares similares
-
Adopting PROs in virtual and outpatient management of RA
por: Taylor, Peter C.
Publicado: (2020) -
Small wonder: nanoparticles feed hydroxychloroquine to activated neutrophils
por: NaveenKumar, Somanathapura K., et al.
Publicado: (2022) -
Primrose homostyles: A classic case of possible balancing selection revisited
por: Charlesworth, Deborah
Publicado: (2022) -
Lipoprotein(a): the underutilized risk factor for cardiovascular disease
por: Khan, TZ, et al.
Publicado: (2019) -
Cardiovascular Research in France
por: Boulanger, Chantal M., et al.
Publicado: (2018)